BioNTech CEO Uğur Şahin reports disposal of USD 6.24 million in common shares

BioNTech CEO Ugur Sahin sold 64,000 ordinary shares on Sept. 17-18, 2026, at prices ranging from USD 96.22 to USD 98.6.

Direct holdings fell to 489,209 shares following the transactions.